Biochemical modification of streptavidin and avidin: In vitro and in vivo analysis

Journal of Nuclear Medicine

Volumn 37, Issue 8, 1996, Pages 1380-1384

  Rosebrough, Scott F ^a   Hartley, Donna F ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

avidin; biotin; in vivo imaging; streptavidin

Indexed keywords

AVIDIN; STREPTAVIDIN;

ACETYLATION; ARTICLE; DEGLYCOSYLATION; DRUG DISTRIBUTION; IMAGE ANALYSIS; ISOELECTRIC FOCUSING; PLASMA CLEARANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANIMALS; AVIDIN; BACTERIAL PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IODINE RADIOISOTOPES; ISOELECTRIC FOCUSING; KIDNEY; LIVER; RABBITS; RADIOIMMUNODETECTION; STREPTAVIDIN; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

EID: 0029738946     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Wilchek M, Bayer EA. The avidin-biotin complex in bioanalytical applications. Anal Biochem 1988;171:1-32.
2. Green NM. Avidin. Av Protein Chem 1975;29:85-133.
3. DeLange RJ. Egg white avidin. I. Amino acid composition; sequence of the amino- and carboxyl-terminal cyanogen bromide peptides. J Biol Chem 1970;245:907-916.
4. Bruch RC, White HB. Compositional and structural heterogeneity of avidin glycopeptides. Biochem 1982;21:5334-5341.
5. Hiller Y, Gershoni JM, Bayer EA, Wilchek M. Biotin binding to avidin. Oligosacharide side chain not required for ligand association. Biochem J 1987;248:167-171.
6. 125I-ligands among the liver cell types. J Cell Biol 1979;83:47-64.
7. Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Ann Rev Biochem 1982;51:531-554.
8. Townsend R, Stahl P. Isolation and characterization of a mannose/N-acetylglucosamine/fucose binding protein from the rat liver. Biochem J 1981;194:209-214.
9. Toth CA, Thomas P. Liver endocytosis and Kupffer cells. Hepatology 1992;16:255-266.
10. Pimm MV, Fells HF, Perkins AC, Baldwin RW. Iodine-131 and indium-111-labeled avidin and streptavidin for pretargeted immunoscintigraphy with biotinylaled anti-tumor monoclonal antibody. Nucl Med Commun 1988;9:931-941.
11. Schechter B, Silberman VR, Arnon R, Wilchek M. Tissue distribution of avidin and streptavidin injected to mice. Eur J Biochem 1990;189:327-331.
12. Rosebrough SF. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin. Nucl Med Biol 1993;20:663-668.
13. Hnatowich DJ, Virzi F, Rusckowski M. Investigation of avidin and biotin for imaging applications. J Nucl Med 1987;28:1294-1302.
14. 111In-labeled biotin derivatives for improved immunotargeting. Nucl Med Biol 1991;18:719-726.
15. Rosebrough SF. Plasma stability and pharmacokinetics of radiolabeled deferoxamine-biotin derivatives. J Pharm Exp Therap 1993;265:408-415.
16. del Rosario RB, Wahl RL. Biotinylated iodo-polylysine for pretargeted radiation delivery. J Nucl Med 1993;34:1147-1151.
17. 125I]lodoaniline: a useful reagent for radiolabeling biotin. Nucl Med Biol 1992;19:297-301.
18. Shoup TM, Fishman AJ, Jaywook S, et al. Synthesis of fluorine-18-labeled biotin derivatives: biodistribution and infection localization. J Nucl Med 1994;35:1685-1690.
19. Vera DR, Stadalnik RC, Krohn KA. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies. J Nucl Med 1985;26:1157-1167.
20. Stadalnik RC, Kudo M, Eckelman WC, Vera DR. In vivo functional imaging using receptor-binding radiopharmaceuticals. Investig Radiol 1993;28:64-70.
21. Ong GL, Ettenson D, Sharkey RM, et al. Galactose-conjugated antibodies in cancer therapy: properties and principles of action. Cancer Res 1991;51:1619-1626.
22. Mattes MJ. Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications. JNCI 1987;79:855-863.
23. Roe JH. The determination of sugar in blood and spinal fluid with anthrone reagent. J Biol Chem 1955;212:335-343.
24. 32P-marked cell methods. J Physiol 1952;116:59-73.
25. Dittmer DS. Biological handbooks: blood and other body. Federation of American Societies for Experimental Biology, 1961:359.
26. Epenetos AA, Snook D, Durbin H, Johnson PM, Taylor-Papadimitriou J. Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res 1986;46:3183-3191.
27. Hnatowich DJ. Recent developments in the radiolabeling of antibodies with iodine, indium, and technetium. Semin Nucl Med 1990;20:80-91.
28. Vaughan ATM, Anderson P, Dykes PW, et al. Limitations to the killing of tumors using radiolabeled antibodies. Br J Radiol 1987;60:567-578.
29. Paganelli G, Riva P, Deleide G, et al. In vivo labeling of biotinylated monoclonal antibodies by radioactive avidin: a strategy to increase tumor radiolocalization. Int J Cancer 1988;2:121-125.
30. Klibanov AL, Martynov AV, Slinkin MA, et al. Blood clearance of radiolabeled antibody: enhancement by lactosamination and treatment with biotin-avidin or anti-mouse IgG antibodies. J Nucl Med 1988;29:1951-1956.
31. Kalofonos HP, Rusckowski M, Siebecker DA, et al. Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl Med 1990;31:1791-1796.
32. Goodwin DA, Meares CF, McCaIl MJ, McTigue M, Chaovapong W. Pretargeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. J Nucl Med 1988;29:226-234.
33. Paganelli G, Belloni C, Magnani P, et al. Two-step tumor targeting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin. Eur J Nucl Med 1992;19:322-329.
34. van Osdol WW, Sung C, Dedrick RL, Weinstein JN. A distribution pharmacokinetic model of two-step imaging and treatment protocols application to streptavidin-conjugated monoclonal antibodies and radiolabeled biotin. J Nucl Med 1993;34:1552-1564.
35. 131I-labeled fibrin-specific monoclonal antibody. Radiology 1985;156: 515-517.
36. 131I-labeled fibrin-specific monoclonal antibody and F(ab′)2 and Fab fragments. J Nucl Med 1988;29:1212-1222.
37. Rosebrough SF, McAfee JG, Grossman, et al. Thrombus imaging: a comparison of radiolabeled GC4 and T2G1s fibrin-specific monoclonal antibodies. J Nucl Med 1990;31:1048-1054.
38. 125I-ligands. J Cell Biol 1979;83:65-81.
39. LaBadie JH, Chapman KP, Aronson JN. Glycoprotein catabolism in rat liver. Biochem J 1975;152:271-279.
40. Vogt A, Rohrbach R, Shimizu F, Takamiya H, Batsford S. Interaction of cationized antigen with rat glomerular basement membrane: in situ immune complex formation. Kidney International 1982;22:27-35.
41. Border WA, Ward HJ, Kamil ES, Cohen AH. induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest 1982;69: 451-461.
42. Kaseda N, Uehara Y, Yamamoto Y, Tanaka K. Induction of in situ immune complexes in rat glomeruli using avidin, a native cation macromolecule. Br J Exp Path 1985;66:729-736.